Patents by Inventor Allen John Lovey

Allen John Lovey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DIAMINOTHIAZOLES
    Publication number: 20040006058
    Abstract: The present invention is directed to novel diaminothiazoles of formula 1
    Type: Application
    Filed: May 5, 2003
    Publication date: January 8, 2004
    Inventors: Xin-Jie Chu, Qingjie Ding, Nan Jiang, Kyungjin Kim, Allen John Lovey, Warren William McComas, John Guilfoyle Mullin, Jefferson Wright Tilley
  • Substituted pyrroles suitable for continuous infusion
    Patent number: 6559164
    Abstract: Disclosed are novel substituted pyrroles having the formula These compounds and their pharmaceutically acceptable salts are suitable for administration to patients as continuous infusion solution and are useful in the treatment and/or control of cell proliferative disorders, in particular cancer. Also disclosed are pharmaceutical compositions containing the foregoing compounds and methods for the treatment and/or control of cancer.
    Type: Grant
    Filed: October 3, 2000
    Date of Patent: May 6, 2003
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Nader Fotouhi, Norman Kong, Emily Aijun Liu, Allen John Lovey, John Guilfoyle Mullin, Jr.
  • Diaminothiazoles having antiproliferative activity
    Publication number: 20020151554
    Abstract: Disclosed are novel diaminothiazoles that are selective inhibitors of Cdk4. These compounds and their pharmaceutically acceptable salts and esters are anti-proliferative agents useful in the treatment or control of solid tumors, in particular breast, colon, lung and prostate tumors. Also disclosed are pharmaceutical compositions containing these compounds as well as intermediates useful in the preparation of the compounds.
    Type: Application
    Filed: January 9, 2002
    Publication date: October 17, 2002
    Inventors: Li Chen, Qingjie Ding, Paul Gillespie, Kyungjin Kim, Allen John Lovey, Warren William McComas, John Guilfoye Mullin, Agostino Perrotta
  • Substituted pyrroles
    Patent number: 6313143
    Abstract: Disclosed are novel substituted pyrroles having the formula These compounds and their pharmaceutically acceptable salts are suitable for administration to patients as continuous infusion solution and are useful in the treatment and/or control of cell proliferative disorders, in particular cancer. Also disclosed are pharmaceutical compositions containing the foregoing compounds and methods for the treatment and/or control of cancer.
    Type: Grant
    Filed: November 7, 2000
    Date of Patent: November 6, 2001
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Nader Fotouhi, Emily Aijun Liu, Allen John Lovey, John Guilfoyle Mullin, Jr., Giuseppe Federico Weber
  • 7-aryl-6(Z)-heptatrienoic acid retinamides
    Patent number: 6310247
    Abstract: Novel trienoic retinoid compounds of with apoptotic activity useful for the prevention and treatment of cancer.
    Type: Grant
    Filed: December 14, 1999
    Date of Patent: October 30, 2001
    Assignee: Hoffmann-LA Roche Inc.
    Inventors: Adrian Wai-Hing Cheung, Stephen B. Ferguson, Louise Helen Foley, Allen John Lovey
  • Substituted pyrroles
    Patent number: 6281356
    Abstract: Disclosed are substituted pyrroles having the formula These compounds and their pharmaceutically acceptable salts are useful in the treatment and/or control of cell proliferative disorders, in particular cancer. Also disclosed are pharmaceutical compositions containing the foregoing compounds.
    Type: Grant
    Filed: December 15, 2000
    Date of Patent: August 28, 2001
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Nader Fotouhi, Norman Kong, Allen John Lovey
  • RXR selective ligands
    Patent number: 5986131
    Abstract: Novel nonatetraenoic acid derivatives which selectively bind to retinoic acid X-receptors (RXR) and which have anti-acne acitvity and which potentiate the activity of retinoids having RAR.alpha. activity are disclosed.
    Type: Grant
    Filed: October 17, 1997
    Date of Patent: November 16, 1999
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Michael Klaus, Allen John Lovey, Peter Mohr, Michael Rosenberger
  • Retinoic acid X-receptor ligands
    Patent number: 5801253
    Abstract: Compounds of formula (I) wherein R.sup.1 -R.sup.7, R.sup.10, X and the dotted bond have the meaning given in the specification, bind selectively to retinoid RXR receptors and are useful as antiproliferative agents for dermatological and oncological indications.
    Type: Grant
    Filed: January 21, 1997
    Date of Patent: September 1, 1998
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Michael Klaus, Allen John Lovey, Peter Mohr, Michael Rosenberger